Geron | GERN - Umsatzkosten





Umsatzkosten Veränderung Datum
Amgen USD 1.87B 271M 2026-06
Bio Techne USD 103.13M 1.47M 2026-03
Cassava Sciences USD 3.96M 1.16M 2025-09
Cytokinetics USD 5.59M 5.43M 2026-06
Exelixis USD 19.95M 6.53M 2026-03
Genmab DKK 84M 19M 2026-06
Geron USD 1.69M 386K 2026-03
Gilead Sciences USD 1000M 445M 2026-06
Incyte USD 104.96M 457K 2026-06
MacroGenics USD 9.53M 585K 2026-03
Novartis USD 3.71B 251M 2026-06
Novavax USD 22.1M 608K 2025-12